These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Centronuclear myopathy with special consideration of the adult form. Goebel HH; Meinck HM; Reinecke M; Schimrigk K; Mielke U Eur Neurol; 1984; 23(6):425-34. PubMed ID: 6542524 [TBL] [Abstract][Full Text] [Related]
27. Chloroquine retinopathy. Lakanapichonchat T J Med Assoc Thai; 1977 Nov; 60(11):576-81. PubMed ID: 591805 [No Abstract] [Full Text] [Related]
28. The motor unit profile of the rat soleus in experimental myopathy and reinnervation. Eisen A; Karpati G; Carpenter S; Danon J Neurology; 1974 Sep; 24(9):878-84. PubMed ID: 4369328 [No Abstract] [Full Text] [Related]
29. An electrophysiological investigation of skeletal muscle in Parkinson's disease. Sica RE; Herskovits E; Aguilera N; Poch G J Neurol Sci; 1973 Apr; 18(4):411-20. PubMed ID: 4349282 [No Abstract] [Full Text] [Related]
30. Ultrastructural alterations in muscle from patients with myasthenia gravis and Eaton-Lumbert syndrome. Bergman RA; Johns RJ Ann N Y Acad Sci; 1971 Sep; 183():88-122. PubMed ID: 5287836 [No Abstract] [Full Text] [Related]
31. [Heart conduction disorders in long-term treatment with chloroquine. Two new cases]. Verny C; de Gennes C; Sébastien P; Lê Thi HD; Chapelon C; Piette JC; Chomette G; Godeau P Presse Med; 1992 May 2-9; 21(17):800-4. PubMed ID: 1535141 [TBL] [Abstract][Full Text] [Related]
32. Chloroquine myopathy and myasthenia-like syndrome. Sghirlanzoni A; Mantegazza R; Mora M; Pareyson D; Cornelio F Muscle Nerve; 1988 Feb; 11(2):114-9. PubMed ID: 3343986 [TBL] [Abstract][Full Text] [Related]
33. Lower tibial than peroneal compound muscle action potential amplitude in neuromuscular diseases. Rubin DI; Whaley NR J Clin Neurophysiol; 2010 Oct; 27(5):341-3. PubMed ID: 20844444 [TBL] [Abstract][Full Text] [Related]
34. The peroneal and tibial nerves in lepromatous leprosy. Clinical and electrophysiologic observations. Swift TR; Hackett ER; Shipley DE; Miner KM Int J Lepr Other Mycobact Dis; 1973; 41(1):25-34. PubMed ID: 4795534 [No Abstract] [Full Text] [Related]
36. Screening for chloroquine retinopathy. Earnshaw ER; Miles DW; Stewart TW Br J Dermatol; 1966 Dec; 78(12):669-74. PubMed ID: 5955593 [No Abstract] [Full Text] [Related]
37. Chloroquine-induced, vitiligo-like depigmentation. Martín-García RF; del R Camacho N; Sánchez JL J Am Acad Dermatol; 2003 Jun; 48(6):981-3. PubMed ID: 12789201 [No Abstract] [Full Text] [Related]
38. Is chloroquine neuromyotoxicity in a patient with refractory discoid lupus erythematosus potentiated by concomitant use of mepacrine? Winn RT; Miller JAL; Meggitt SJ Clin Exp Dermatol; 2018 Dec; 43(8):927-928. PubMed ID: 29808483 [No Abstract] [Full Text] [Related]
39. [Topical treatment of discoid lupus erythematosus by injections of quingamine]. Shinskiĭ GE Vestn Dermatol Venerol; 1966 Feb; 40(2):26-9. PubMed ID: 5973006 [No Abstract] [Full Text] [Related]
40. [Behavior of lymphocytotoxic antibodies during the chloroquine treatment of discoid lupus erythematosus]. Nagy E; Stenszky V; Szerze P Dermatol Monatsschr; 1975 Aug; 161(8):609-11. PubMed ID: 1081959 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]